【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Incontinence Devices Overview 13
3 Products under Development 15
3.1 Incontinence Devices – Pipeline Products by Stage of Development 15
3.2 Incontinence Devices – Pipeline Products by Segment 16
3.3 Incontinence Devices – Pipeline Products by Territory 17
3.4 Incontinence Devices – Pipeline Products by Regulatory Path 18
3.5 Incontinence Devices – Pipeline Products by Estimated Approval Date 19
3.6 Incontinence Devices – Ongoing Clinical Trials 20
4 Incontinence Devices – Pipeline Products under Development by Companies 21
4.1 Incontinence Devices Companies – Pipeline Products by Stage of Development 21
4.2 Incontinence Devices – Pipeline Products by Stage of Development 24
5 Incontinence Devices Companies and Product Overview 27
5.1 American Medical Systems Holdings, Inc. Company Overview 27
5.1.1 American Medical Systems Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Applied Catheter Technologies Inc. Company Overview 34
5.2.1 Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.3 AugmentRx Medical Inc. Company Overview 35
5.3.1 AugmentRx Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.4 Bioring SA (Inactive) Company Overview 36
5.4.1 Bioring SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36
5.5 BioSurfaces, Inc. Company Overview 37
5.5.1 BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Boston Scientific Corporation Company Overview 38
5.6.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
5.7 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 44
5.7.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 44
5.8 Compactcath, Inc. Company Overview 45
5.8.1 Compactcath, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
5.9 Continara Limited (Inactive) Company Overview 46
5.9.1 Continara Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46
5.10 Continental Dry-Works Company Overview 47
5.10.1 Continental Dry-Works Pipeline Products & Ongoing Clinical Trials Overview 47
5.11 Covalon Technologies Ltd. Company Overview 48
5.11.1 Covalon Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 48
5.12 DUALIS MedTech GmbH Company Overview 50
5.12.1 DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 Elidah, LLC Company Overview 52
5.13.1 Elidah, LLC Pipeline Products & Ongoing Clinical Trials Overview 52
5.14 EMKinetics, Inc. Company Overview 53
5.14.1 EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.15 Endo International Plc Company Overview 54
5.15.1 Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview 54
5.16 EndoStim, Inc Company Overview 56
5.16.1 EndoStim, Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.17 Enox Biopharma, Inc Company Overview 57
5.17.1 Enox Biopharma, Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.18 Ethicon, Inc. Company Overview 58
5.18.1 Ethicon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.19 Facet Technologies, LLC Company Overview 60
5.19.1 Facet Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 60
5.20 FLEXIPROBE LTD. Company Overview 61
5.20.1 FLEXIPROBE LTD. Pipeline Products & Ongoing Clinical Trials Overview 61
5.21 Floelle Inc. Company Overview 62
5.21.1 Floelle Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.22 Forconti Medical Ltd. Company Overview 63
5.22.1 Forconti Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 63
5.23 Future Path Medical Holding, LLC Company Overview 64
5.23.1 Future Path Medical Holding, LLC Pipeline Products & Ongoing Clinical Trials Overview 64
5.24 Generic Medical Devices, Inc. Company Overview 65
5.24.1 Generic Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.25 GR Dome Medical Ltd. Company Overview 66
5.25.1 GR Dome Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
5.26 GT Urological, LLC Company Overview 67
5.26.1 GT Urological, LLC Pipeline Products & Ongoing Clinical Trials Overview 67
5.27 Jabil, Inc. Company Overview 73
5.27.1 Jabil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.28 Kleeven International BV Company Overview 74
5.28.1 Kleeven International BV Pipeline Products & Ongoing Clinical Trials Overview 74
5.29 Leto Medical, LLC Company Overview 75
5.29.1 Leto Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 75
5.30 Lilium Otsuka Co., Ltd. Company Overview 76
5.30.1 Lilium Otsuka Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 76
5.31 Marvao Medical Devices Limited Company Overview 77
5.31.1 Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 77
5.32 Medici Medical Srl Company Overview 78
5.32.1 Medici Medical Srl Pipeline Products & Ongoing Clinical Trials Overview 78
5.33 Medi-Globe GmbH Company Overview 79
5.33.1 Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 79
5.34 Medisse BV Company Overview 80
5.34.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 80
5.35 Medtronic plc Company Overview 81
5.35.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 81
5.36 MyoPowers Medical Technologies SA Company Overview 83
5.36.1 MyoPowers Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 83
5.37 Nagasaki University Company Overview 85
5.37.1 Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 85
5.38 NexHand Company Overview 86
5.38.1 NexHand Pipeline Products & Ongoing Clinical Trials Overview 86
5.39 Olympus Medical Systems Corp. Company Overview 87
5.39.1 Olympus Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview 87
5.40 PercuVision LLC Company Overview 88
5.40.1 PercuVision LLC Pipeline Products & Ongoing Clinical Trials Overview 88
5.41 Precision Medical Devices, Inc. Company Overview 89
5.41.1 Precision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 89
5.42 Prosurg, Inc. Company Overview 91
5.42.1 Prosurg, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
5.43 Proxy Biomedical Limited Company Overview 93
5.43.1 Proxy Biomedical Limited Pipeline Products & Ongoing Clinical Trials Overview 93
5.44 Quick-Med Technologies, Inc. Company Overview 94
5.44.1 Quick-Med Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
5.45 Salusion B.V. Company Overview 97
5.45.1 Salusion B.V. Pipeline Products & Ongoing Clinical Trials Overview 97
5.46 Sharklet Technologies, Inc. Company Overview 98
5.46.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 98
5.47 Solace Therapeutics Company Overview 100
5.47.1 Solace Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 100
5.48 Teleflex Incorporated Company Overview 105
5.48.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 105
5.49 Tengion, Inc. Company Overview 108
5.49.1 Tengion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 108
5.50 The Feinstein Institute for Medical Research Company Overview 110
5.50.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 110
5.51 The University of Utah Company Overview 113
5.51.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 113
5.52 TheraNova, LLC. Company Overview 116
5.52.1 TheraNova, LLC. Pipeline Products & Ongoing Clinical Trials Overview 116
5.53 Universitat Politecnica de Catalunya Company Overview 117
5.53.1 Universitat Politecnica de Catalunya Pipeline Products & Ongoing Clinical Trials Overview 117
5.54 University of Basel Company Overview 119
5.54.1 University of Basel Pipeline Products & Ongoing Clinical Trials Overview 119
5.55 University of California, San Diego Company Overview 120
5.55.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 120
5.56 University of Michigan Pediatric Device Consortium Company Overview 121
5.56.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 121
5.57 University of Nottingham Company Overview 122
5.57.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 122
5.58 Urinary BioSolutions LLC Company Overview 123
5.58.1 Urinary BioSolutions LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.59 Uromedica, Inc. Company Overview 124
5.59.1 Uromedica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.60 Urova Medical Inc. Company Overview 130
5.60.1 Urova Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.61 Urovalve, Inc. Company Overview 131
5.61.1 Urovalve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 131
5.62 Verathon Inc. Company Overview 134
5.62.1 Verathon Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.63 Vesiflo, Inc. Company Overview 137
5.63.1 Vesiflo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.64 Victhom Human Bionics Inc. (Inactive) Company Overview 138
5.64.1 Victhom Human Bionics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 138
5.65 Vysera Biomedical Limited Company Overview 139
5.65.1 Vysera Biomedical Limited Pipeline Products & Ongoing Clinical Trials Overview 139
5.66 Xennovate Medical LLC Company Overview 140
5.66.1 Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 140
6 Incontinence Devices- Recent Developments 142
7 Appendix 229
7.1 Methodology 229
7.2 About GlobalData 231
7.3 Contact Us 232
7.4 Disclaimer 232
【レポート販売概要】
■ タイトル:世界における失禁用デバイスの製品パイプライン動向2015■ 英文:Incontinence Devices - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0092EPD
■ 調査対象地域:グローバル
- Atlantic Petroleum P/F:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Atlantic Petroleum P/F Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Atlantic Petroleum P/F Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- チリの発電市場2016:市場動向、制度、競争状況Chile Power Market Outlook to 2030, Update 2016 - Market Trends, Regulations, and Competitive Landscape Summary This report elaborates Chile's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Chile power market’s regulatory structure, import and export trends, competitive landscape, and power projects …
- IoTセキュリティ及びプライバシーの世界市場:課題、市場機会及び予測The Internet of Things (IoT) has the potential to become as silent, hidden, omnipresent, and essential as the air to modern society. Like the air, IoT also has virtually limitless access points and vulnerabilities. While initially hackers have been largely a nuisance, Mind Commerce anticipates that their intrusions will become increasingly impactful leading to the potential for operational disrupt …
- 潤滑油添加剤の世界市場予測(~2023年):分散剤、洗浄剤、酸化防止剤、摩耗防止剤、極圧添加剤、粘度指数向上剤The increasing demand for oil additives in various applications in the automotive and industrial sectors is driving the growth of the lubricating oil additives market. In terms of value, the global lubricating oil additives market is estimated to be USD 15.57 Billion in 2018 and is projected to reach USD 17.74 Billion by 2023, at a CAGR of 2.64% between 2018 and 2023. Based on functional type, the …
- スマート輸送の世界市場:ソリューション別(駐車、交通管理、統合監視)、サービス別(クラウド、ビジネス、専門)、セグメント予測The global smart transportation market size is estimated to reach USD 285.12 billion by 2024, according to a new study by Grand View Research, Inc., registering a CAGR of 22.5% during the forecast period. Rising number of on-road vehicles and ineffective existing transport infrastructure are expected to propel the need for efficient management systems. Favorable government initiatives for building …
- RFID Deployment and Analysis with Business Plan and Company AnalysisRadio Frequency Identification (RFID) is proving to be one of the best solutions for tracking and identifying assets globally. It can be used for many functions including locating items, provide quick identification and tracking of medicines in the hospitals, tracking animals, etc. RFID can be deployed in various market verticals for tracking and managing moveable assets. It is arguably the most p …
- 半導体資本設備の世界市場2019-2023About this market Owing to the rising need for semiconductor memory devices due to the rapidly advancing dynamics of consumer electronics, the semiconductor memory devices market demand is expected to rise throughout the forecast period. Technavio’s analysts have predicted that the semiconductor capital equipment market will register a CAGR of more than 6% by 2023. Market Overview Rising number of …
- ベータラクタム及びベータラクタマーゼ阻害剤の世界市場:薬物クラス別、疾患別、投与経路別The global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. Beta-lactam and beta-lactamase inhibitors is a most important type of antibacterial agent used for fighting bacterial infections. In addition, these are used to kill or prevent the growth of microorganisms. Bas …
- 世界のスマート・ライティング市場:Global Smart Lighting Market 2014-2018TechNavio's analysts forecast the Global Smart Lighting market to grow at a CAGR of 36.4 percent over the period 2013-2018. One of the key factors contributing to this market growth is the energy-efficient lighting from industries worldwide. The Global Smart Lighting market has also been witnessing rapid technological advancements. However, the high cost of replacement of lighting could pose a cha …
- 原子力業界のM&A及び投資動向2012Nuclear Energy Annual Deals Analysis: M&A and Investments Trends - 2012 Summary GlobalData’s “Nuclear Energy Annual Deals Analysis: M&A and Investments Trends - 2012” report is an essential source of data and trend analysis on the mergers and acquisitions (M&A) and financings in the alternative energy market. The report provides detailed information on mergers and acquisitions (M&A), equity/debt o …
- 医療用メンブレンの世界市場予測(~2022年)“The medical membranes market is projected to grow at CAGR of 9.2% from 2017 to 2022.”The medical membranes market is projected to grow from USD 2.13 billion in 2017 to USD 3.31 billion by 2022, at a CAGR of 9.2% during the forecast period. The demand for medical membranes is expected to increase in the near future, owing to the rising prevalence of ESRD, globally. Membranes are required for filtr …
- アクリル系加工助剤の世界市場予測(~2026): ポリマー種類別(PVC)、製造工程別(押出成形、射出成形)、需要先別The global acrylic processing aid (APA) market was USD 645.4 Million in 2016, and is projected to reach USD 1,173.6 Million by 2026, registering a CAGR of 6.2% between 2016 and 2026. The increasing demand for APA based PVC in end-use applications drives the APA market. The APA market is classified on the basis of polymer type into polyvinylchloride (PVC) and others. PVC dominated the APA market, i …
- 防曇添加剤の世界市場:グリセロールエステル、ポリグリセロールエステル、ソルビタン脂肪酸エステル、エトキシル化ソルビタンエステル、オレイン酸ポリオキシエチレンエステル、ゼラチン、二酸化チタンThe global antifog additives market is projected to reach USD 1.74 Billion by 2020, at a CAGR of 7.3% between 2015 and 2020. Rising demand for antifog additive films from the food packaging and agricultural sectors and the increasing demand for packed food items are major factors influencing the growth of this market. Among all applications, the food packaging films segment led the global antifog …
- バーチャル網膜ディスプレイの世界市場2016-2020About Global Virtual Retinal Display MarketVRD, also called as retinal scan display (RSD), is a display technology that uses power laser beam as a light source, which is projected onto the retina of the user. The VRD scans the images on the retina of the user to display images in real-time. Technavio’s analysts forecast the global virtual retinal display market to grow at a CAGR of 3.64% during th …
- アメリカの術中神経機能モニタリング(IONM)市場2016-2020Technavio market research analyst expects the intraoperative neuromonitoring (IONM) market in the US to grow at a CARG of over 9% during the forecast period. IONM, which is a combination of surgical medicine and neuroscience, is one of the fastest-growing areas in the US. Many start-up companies started offering neuromonitoring services to surgeons, and hospitals for orthopaedic, neurosurgery, spi …